Skip to main content

Poolbeg Pharma announces expansion of POLB 001 into oncology

--News Direct--

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-announces-expansion-of-polb-001-into-oncology-711615119

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
+0.00 (0.00%)
AAPL  252.29
+0.00 (0.00%)
AMD  233.08
+0.00 (0.00%)
BAC  51.28
+0.00 (0.00%)
GOOG  253.79
+0.00 (0.00%)
META  716.91
+0.00 (0.00%)
MSFT  513.58
+0.00 (0.00%)
NVDA  183.16
-0.06 (-0.03%)
ORCL  291.31
+0.00 (0.00%)
TSLA  439.31
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.